Influenza diagnostics market to rise at 7.22% CAGR until 2028

Thanks to a rising demand for rapid and accurate diagnostic tests.

The global market for influenza diagnostics is expected to grow by $517.5m until 2028 at a compound annual growth rate (CAGR) of 7.22%.

A report by Technavio revealed that the market is experiencing significant growth amidst the rising demand for rapid and accurate diagnostic tests, further driven by the need for early influenza detection and treatment.

“Technologies such as rapid antigen detection and molecular diagnostics are gaining popularity for their speed and accuracy,” the report said.

In line with this, the market anticipates continuous growth in the coming years with the development of innovations and technologies.

Meanwhile, by end-user, the hospital and diagnostic laboratories segment is determined as a major player in the global market due to efficient and accurate tools being crucial for healthcare providers.

“Advanced technologies like rapid antigen tests, molecular assays, and serological tests enable prompt diagnosis and effective patient management. These advancements are expected to fuel market growth during the forecast period,” the report added.